Brivanib Exhibits Potential for Pharmacokinetic Drug-Drug Interactions and the Modulation of Multidrug Resistance through the Inhibition of Human ABCG2 Drug Efflux Transporter and CYP450 Biotransformation Enzymes
Author: | Jakub Hofman, Ales Sorf, Dimitrios Vagiannis, Simona Sucha, Sarah KammererORCiD, Jan-Heiner KüpperGND, Si Chen, Lei Guo, Martina Ceckova, Frantisek Staud |
---|---|
DOI: | https://doi.org/10.1021/acs.molpharmaceut.9b00361 |
Title of the source (English): | Molecular Pharmaceutics |
Document Type: | Scientific journal article peer-reviewed |
Language: | English |
Year of publication: | 2019 |
Volume/Year: | 16 |
Issue number: | 11 |
First Page: | 4436 |
Last Page: | 4450 |
Faculty/Chair: | Fakultät 2 Umwelt und Naturwissenschaften / FG Molekulare Zellbiologie |